Long-Term Treatment With First-Line Ocrelizumab in Patients With Early RMS: 9-Year OPERA Subgroup Analysis (S46.002)

Author:

Cerqueira Joao1,Berthele Achim2,Cree Bruce3,Filippi Massimo4,Pardo Gabriel5,Pearson Owen6,Traboulsee Anthony7,Ziemssen Tjalf8,Vollmer Timothy9,Bernasconi Corrado10,Mandel Corey11,Kulyk Inessa10,Chognot Cathy10,Schneble Hans-Martin10,Prajapati Kalpesh12,Havrdova Eva13

Affiliation:

1. 2CA-Clinical Academic Centre Braga, Portugal Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal

2. Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany

3. Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA

4. Neurology Unit, Neurophysiology Service, Neurorehabilitation Unit, Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy

5. Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

6. Department of Neurology, Morriston Hospital, Swansea, UK

7. Department of Neurology, University of British Columbia, Vancouver, BC, Canada

8. Center of Clinical Neuroscience, Department of Neurology, University Clinic Carl Gustav Carus, Dresden University of Technology, Dresden, Germany

9. Department of Neurology, Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus, University of Colorado Denver, Denver, CO, USA

10. F. Hoffmann-La Roche Ltd, Basel, Switzerland

11. Genentech, Inc., San Francisco, CA, USA

12. IQVIA Solutions, Inc., Amsterdam, The Netherlands

13. Department of Neurology and Center of Clinical Neuroscience, General University Hospital and Charles University, Prague, Czech Republic

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3